Literature DB >> 18842507

Posttransplantation lymphoproliferative disorder involving the central nervous system in liver transplant recipients.

Qing-Sheng Xu1, Song Ye, Yong-Qing Zhou, Jian-Feng Sheng, Ke Ye, Shu-Sen Zheng.   

Abstract

BACKGROUND: Posttransplantation lymphoproliferative disorder (PTLD) involving the central nervous system (CNS) is a rare and serious complication associated with solid organ transplantation. We treated a case of PTLD with CNS involvement in a liver transplant recipient and reviewed the literature.
METHOD: The clinicopathological features of a 53-year-old man were retrospectively analyzed.
RESULTS: Metastasis of the hepatoma was preoperatively considered on the basis of clinical findings. Craniotomy was performed and PTLD was diagnosed pathologically. The patient was treated with antiviral agents, radiation therapy, and chemotherapy; the immunosuppressive medication was reduced. The patient is still alive after follow-up for 14 months.
CONCLUSIONS: Definitive diagnosis of PTLD is only established on the basis of histopathologic evaluation of the tissue. Although there are several ways to manage PTLD with CNS involvement, the prognosis is still poor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18842507

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  3 in total

1.  Post-transplantation primary central nervous system lymphoma: A case report and review of the literature.

Authors:  Arthur P Chou; Shadi Lalezari; Brendan M Fong; Justin Dye; Tracie Pham; Harry V Vinters; Nader Pouratian
Journal:  Surg Neurol Int       Date:  2011-09-27

2.  PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis.

Authors:  A Stravodimou; A Cairoli; T Rausch; R Du Pasquier; P Michel
Journal:  Case Rep Med       Date:  2012-01-19

3.  Treatment of recurrent posttransplant lymphoproliferative disorder of the central nervous system with high-dose methotrexate.

Authors:  Clare J Twist; Ricardo O Castillo
Journal:  Case Rep Transplant       Date:  2013-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.